Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spike Glycoprotein, Coronavirus | 11 | 2024 | 184 | 3.280 |
Why?
|
| Viral Vaccines | 5 | 2021 | 334 | 1.940 |
Why?
|
| Recombinant Proteins | 12 | 2023 | 1392 | 1.900 |
Why?
|
| Lyme Disease | 5 | 2025 | 35 | 1.590 |
Why?
|
| Borrelia burgdorferi | 4 | 2025 | 18 | 1.420 |
Why?
|
| Vaccines, Synthetic | 4 | 2021 | 318 | 1.290 |
Why?
|
| Betacoronavirus | 2 | 2020 | 286 | 1.070 |
Why?
|
| Saccharomycetales | 5 | 2021 | 37 | 1.050 |
Why?
|
| Ixodes | 2 | 2022 | 15 | 1.000 |
Why?
|
| Coronavirus Infections | 3 | 2021 | 358 | 0.980 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 374 | 0.940 |
Why?
|
| Vaccines, Subunit | 2 | 2024 | 67 | 0.920 |
Why?
|
| Pandemics | 3 | 2021 | 1102 | 0.910 |
Why?
|
| Protozoan Proteins | 2 | 2022 | 108 | 0.890 |
Why?
|
| Protein Domains | 7 | 2021 | 234 | 0.880 |
Why?
|
| Phlebotomus | 2 | 2020 | 17 | 0.850 |
Why?
|
| Leishmaniasis Vaccines | 2 | 2020 | 20 | 0.850 |
Why?
|
| Gene Expression | 4 | 2021 | 1569 | 0.780 |
Why?
|
| Trypanosoma cruzi | 2 | 2022 | 232 | 0.770 |
Why?
|
| Pichia | 2 | 2017 | 56 | 0.670 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 151 | 0.650 |
Why?
|
| Chagas Disease | 2 | 2022 | 290 | 0.640 |
Why?
|
| Chromatography, Ion Exchange | 4 | 2014 | 68 | 0.610 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2023 | 426 | 0.590 |
Why?
|
| Lyme Disease Vaccines | 4 | 2025 | 12 | 0.550 |
Why?
|
| Mice, Inbred BALB C | 6 | 2024 | 1006 | 0.540 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 1149 | 0.390 |
Why?
|
| Animals | 19 | 2025 | 34139 | 0.380 |
Why?
|
| Alum Compounds | 3 | 2022 | 41 | 0.350 |
Why?
|
| Salivary Proteins and Peptides | 2 | 2020 | 19 | 0.350 |
Why?
|
| Insect Proteins | 2 | 2020 | 99 | 0.340 |
Why?
|
| Mice | 11 | 2025 | 17725 | 0.330 |
Why?
|
| Cloning, Molecular | 3 | 2021 | 892 | 0.330 |
Why?
|
| Protozoan Vaccines | 2 | 2022 | 96 | 0.330 |
Why?
|
| Antibodies, Neutralizing | 6 | 2024 | 464 | 0.330 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2020 | 36 | 0.310 |
Why?
|
| Adjuvants, Immunologic | 3 | 2024 | 380 | 0.310 |
Why?
|
| Complement Factor H | 3 | 2025 | 21 | 0.290 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 886 | 0.280 |
Why?
|
| RNA | 1 | 2010 | 568 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2025 | 393 | 0.260 |
Why?
|
| DNA | 1 | 2010 | 1598 | 0.240 |
Why?
|
| Epitopes | 2 | 2022 | 432 | 0.220 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2024 | 101 | 0.220 |
Why?
|
| Vaccines, Combined | 1 | 2022 | 39 | 0.200 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2022 | 5 | 0.200 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 31 | 0.200 |
Why?
|
| Interleukin-4 | 1 | 2022 | 139 | 0.200 |
Why?
|
| Antibodies, Protozoan | 1 | 2022 | 75 | 0.200 |
Why?
|
| Viral Load | 2 | 2021 | 384 | 0.190 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2012 | 87 | 0.190 |
Why?
|
| Borrelia | 1 | 2022 | 68 | 0.180 |
Why?
|
| Fermentation | 2 | 2020 | 66 | 0.180 |
Why?
|
| Aluminum Hydroxide | 1 | 2020 | 40 | 0.180 |
Why?
|
| Leishmania | 1 | 2020 | 28 | 0.170 |
Why?
|
| Humans | 20 | 2025 | 124398 | 0.170 |
Why?
|
| Adsorption | 4 | 2014 | 32 | 0.170 |
Why?
|
| Ticks | 1 | 2020 | 30 | 0.170 |
Why?
|
| Pepsin A | 1 | 2019 | 12 | 0.170 |
Why?
|
| Aspartic Acid Proteases | 1 | 2019 | 9 | 0.170 |
Why?
|
| Cytokines | 2 | 2022 | 1279 | 0.170 |
Why?
|
| Protein Subunits | 1 | 2020 | 164 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 755 | 0.160 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 204 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2699 | 0.150 |
Why?
|
| Proteins | 2 | 2014 | 1043 | 0.140 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 65 | 0.140 |
Why?
|
| Industrial Microbiology | 1 | 2017 | 6 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 324 | 0.130 |
Why?
|
| Stochastic Processes | 1 | 2014 | 34 | 0.110 |
Why?
|
| Spermine | 1 | 2013 | 5 | 0.110 |
Why?
|
| Sepharose | 1 | 2013 | 16 | 0.110 |
Why?
|
| Levivirus | 1 | 2013 | 3 | 0.110 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2013 | 21 | 0.110 |
Why?
|
| Glycosylation | 1 | 2013 | 119 | 0.110 |
Why?
|
| HIV Infections | 1 | 2025 | 1891 | 0.110 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 134 | 0.100 |
Why?
|
| Aptamers, Nucleotide | 1 | 2013 | 28 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2508 | 0.100 |
Why?
|
| Salmon | 1 | 2010 | 5 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2013 | 233 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 177 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 411 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2010 | 92 | 0.090 |
Why?
|
| Female | 7 | 2025 | 66305 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2025 | 475 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 223 | 0.080 |
Why?
|
| Antibodies | 2 | 2022 | 371 | 0.080 |
Why?
|
| Peptides | 1 | 2012 | 793 | 0.080 |
Why?
|
| Protein Stability | 2 | 2020 | 165 | 0.080 |
Why?
|
| Binding Sites | 2 | 2022 | 1294 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2025 | 1074 | 0.070 |
Why?
|
| Namibia | 1 | 2025 | 4 | 0.060 |
Why?
|
| South Africa | 1 | 2025 | 100 | 0.060 |
Why?
|
| Freeze Drying | 1 | 2024 | 15 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 109 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2024 | 195 | 0.060 |
Why?
|
| Lactalbumin | 2 | 2014 | 11 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2025 | 358 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2024 | 121 | 0.050 |
Why?
|
| Protein Binding | 2 | 2021 | 1747 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2024 | 107 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 386 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2025 | 313 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2025 | 502 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 64 | 0.050 |
Why?
|
| Cattle | 2 | 2013 | 563 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 120 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 548 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 180 | 0.040 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2020 | 48 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2020 | 392 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 118 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2020 | 58 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 493 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2019 | 44 | 0.040 |
Why?
|
| Health Resources | 1 | 2021 | 115 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 1015 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 426 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 218 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 772 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2024 | 987 | 0.040 |
Why?
|
| Freezing | 1 | 2017 | 28 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 833 | 0.040 |
Why?
|
| Temperature | 1 | 2017 | 304 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2020 | 940 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1085 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2770 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2873 | 0.030 |
Why?
|
| RNA, Fungal | 1 | 2013 | 14 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2014 | 63 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 2013 | 14 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 48 | 0.030 |
Why?
|
| Muramidase | 1 | 2013 | 93 | 0.030 |
Why?
|
| Chickens | 1 | 2013 | 637 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1697 | 0.030 |
Why?
|
| Ligands | 1 | 2013 | 535 | 0.020 |
Why?
|
| Kinetics | 1 | 2014 | 1321 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 83 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 368 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3873 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 19479 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 26459 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 29396 | 0.010 |
Why?
|
| Male | 1 | 2021 | 61025 | 0.010 |
Why?
|